ACR 2024: Preview Podcast

The discussion kicks off with a look at the ACR 2024 Congress, spotlighting essential sessions and resources for rheumatologists. Guzelcomab takes center stage as experts reveal its promising role in Psoriatic Arthritis, particularly its effectiveness compared to traditional treatments. Delving deeper, innovations like bimikizumab and secukinamab offer fresh perspectives on therapy options. Revolutionary findings in interstitial lung disease treatments are also highlighted, emphasizing personalized approaches. The potential of biosimilars and the push for early intervention complete the insightful exploration.